The study of the diuretic activity and pharmacotechnological properties of a dry extract of Salvia sclarea L. growing in Tajikistan

Authors

DOI:

https://doi.org/10.24959/nphj.24.139

Keywords:

clary sage (Salvia sclarea L.); dry extract; diuretic activity; pharmacotechnological properties; technology of solid dosage forms, hard gelatin capsules

Abstract

Aim. To study the pharmacological activity of a dry extract of clary sage (DECS) growing in Tajikistan and its pharmacotechnological properties as basic stages in the development of the composition and technology of hard gelatin capsules with its content.

Materials and methods. For the studies, we used DECS standardized by the content of the total amount of flavonoids and hydroxycinnamic acids. The quantitative content of the total amount of flavonoids was not less than 13.0 % calculated with reference to apigenin, and the quantitative content of the total amount of hydroxycinnamic acids was not less than 1.2 % calculated with reference to rosmarinic acid. The pharmacotechnological properties of DECS were studied according to methods of the State Pharmacopoeia of Ukraine (SPhU).

Results and discussion. During screening, all doses of DECS studied showed a moderate diuretic activity. Thus, when using DECS in the dose of 100 mg/kg, the relative volume of the urine excreted by rats for 5 hours increased by 1.9 times, in the dose of 200 mg/kg – by 2.0 times, in the dose of 300 mg/kg – by 1.8 times compared to the same indicator in the negative control group (p˂0.05). When studying the complex of pharmacotechnological properties, it was found that DECS was a finely dispersed amorphous powder with particles of isodiametric form. DECS had an average bulk weight of 0.515 ± 0.002 g/mL, and the fluidity assessment showed that DECS had a very poor flowability, which value in the vibration mode of the device was 2.8 ± 0.1 g/s. According to the study of the fractional composition, DECS had a clearly expressed fine fraction with a particle size of less than 0.25-0.09 mm 84.68 %.

Conclusions. Taking into account the results of the study of the diuretic activity and scientific literature data on the spectrum of the pharmacological activity of Salvia sclarea L, it is rational to consider DECS as a potential combined agent for enhancing the diuretic effect or in diseases of the urinary system accompanied by edema and inflammatory processes. The study of the pharmacotechnological indicators of DECS allows predicting the need to use certain groups of excipients to develop the composition and technology of capsules with its content, namely antifriction substances to improve fluidity and disintegrants to improve capsule disintegration, as well as substances that contribute to the compaction of bulk mass and moisture-regulating agents.

Author Biographies

S. B. Kholov, Tajik National University, Dushanbe, Tajikistan

Postgraduate student of the Department of Pharmaceutical Technology and Pharmacology

S. M. Musozoda, Tajik National University, Dushanbe, Tajikistan

 Doctor of Pharmacy (Dr. habil.), professor of the Department of Pharmaceutical Technology and Pharmacology

D. V. Lytkin, National University of Pharmacy of the Ministry of Health of Ukraine, Kharkiv

Candidate of Biology (Ph.D.), Deputy Director of the Educational and Scientific Institute of Applied Pharmacy

U.P. Yuldasheva, AvicennaTajik State Medical University, Dushanbe, Tajikistan

Candidate of Medicine (Ph.D.), associate professor of the Department of Pharmacology

H.P. Kukhtenko, National University of Pharmacy of the Ministry of Health of Ukraine, Kharkiv

Candidate of Pharmacy (Ph.D.), associate professor of the Department of Cosmetology and Aromatology

References

Hudz, N. I., Shanaida, M. I., Darmohrai, R. Ye. (2020). Shavliia likarska (Salvia officinalis L.): perspektyvy vykorystannia syrovyny yak dzherela roslynnykh preparativ antyoksydantnoi ta antymikrobnoi dii. Vistnyk farmatsi, 2, (100), 11-19.

Nizhenkovska, I. V., Tsurkan, O. O., Sedko, K. V. (2014). Shavliia likarska – suchasni aspekty zastosuvannia (Ohliad literatury). Fitoterapiia. Chasopys, 2, 58-61.

Koshovyi, O. M., Raal, A., Kovaleva, A. M., Myha, M. M., Ilina, T. V., Borodina, N. V. et al. (2020). The phytochemical and chemotaxonomic study of Salvia spp. growing in Ukraine. Journal of Applied Biology & Biotechnology, 8, (03), 29-36.

Myha, M. M., Koshovyi, O. M., Hamulia, O. V., Verkhovodova, Yu. V., Kireiev, I. V., Komisarenko A. M. (2020). Porivnialne farmakohnostychne ta farmakolohichne doslidzhennia lystia Salvia verticillata ta Salvia officinalis dlia vstanovlennia perspektyvy stvorennia novoho likarskoho zasobu. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 13, 1, 61-71.

Verkhovodova, Yu. V., Kireiev, I. V., Koshovyi, O. M., Myha, M. M. (2019). Doslidzhennia antyeksudatyvnoi aktyvnosti ekstraktiv z lystia Salvia officinalis. Medychna ta klinichna khimiia, 21, 4, 54-60.

Bones, M., Loizzo,M. R., Acquaviva, R., Malfa, G. A., Aiello, F., Tundis, R. (2017). Anti-inflammatory and Antioxidant Agents from Salvia Genus (Lamiaceae): An Assessment of the Current State of Knowledge. Anti–Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 16, (2), 70-86. doi: 10.2174/1871523016666170502121419.

Kostić, M., Kitić, D., Petrović, M. B., Jevtović-Stoimenov, T., Jović, M., Petrović, A. et al. (2017). Anti-inflammatory effect of the Salvia sclarea L. ethanolic extract on lipopolysaccharide–induced periodontitis in rats. Journal of Ethnopharmacology, 199, 52-59. doi: 10.1016/j.jep.2017.01.020.

Jasicka–Misiak, I., Poliwoda, A., Petecka, M., Buslovych, O., Shlyapnikov, V. A., Wieczorek, P. P. (2018). Antioxidant Phenolic Compounds in Salvia officinalis L. and Salvia sclarea L. Ecological Chemistry and Engineering S., 25, (1), 133-142. doi: 10.1515/eces-2018-0009.

Mervić, M., Bival Štefan, M., Kindl, M., Blažeković, B., Marijan, M., Vladimir-Knežević, S. (2022). Comparative Antioxidant, Anti–Acetylcholinesterase and Anti-α-Glucosidase Activities of Mediterranean Salvia Species. Plants, 11 (5), 625. doi: 10.3390/plants11050625.

Dudonne Xavier Vitrac, S., Philippe Coutière, Marion Woillez, Jean-Michel Mérillon (2009). Comparative study of antioxidant properties and total phenolic content of 30 plant extracts of industrial interest using DPPH, ABTS, FRAP, SOD, and ORAC assays. J. Agric. Food Chem, 57, 1768-1774. doi: 10.1021/jf803011r.

Wu Zhi-Yu Ni, Y.-B., Qing-Wen Shi, Mei Dong, Hiromasa Kiyota, Yu-Cheng Gu, Bin Cong (2012). Constituents from Salvia Species and Their Biological Activities. Chemical Reviews, 112 (11), 5967-6026. doi: 10.1021/cr200058f

Firuzi, O., Miri, R., Asadollahi, M., Eslami, S., Reza Jassbi, A. (2013). Cytotoxic, antioxidant and antimicrobial activities and phenolic contents of eleven Salvia species from Iran. Iran. J. Pharm. Res, 12, 4. 801-810.

Durling, N. E., Catchpole O. J., Grey, J. B., Webby, R. F., Mitchell, K. A., Foo, L. Y. et al. (2007). Extraction of phenolics and essential oil from dried sage (Salvia officinalis) using ethanol–water mixtures. Food Chemistry, 101 (4), 1417-1424. doi: 10.1016/j.foodchem.2006.03.050.

Verkhovodovoda, Y. V., Kireyev, I. V., Koshovyi, O. M., Osolodchenko, T. P. (2019). In vitro antimicrobial study of new modifications of salvia officinalis extracts. Annals of Mechnikov Institute, 1, 31-35. doi: 10.5281/zenodo.2639493.

Koshovyi, O. M., Perederii, Ye. O., Osolodchenko, T. P., Kovalova, A. M. Komisarenko, A. M. (2011). Doslidzhennia izoprenoidnoho skladu ta antymikrobnoi aktyvnosti hustoho ekstraktu lystia shavlii likarskoi. Klinichna farmatsiia, 15, 1, 26-29.

Dolia, V. S., Trzhetsynskyi, S. D., Mozul, V. Y., Tretiak N. Y. (2013). Osobennosty khymycheskoho sostava vydov roda Salvia L. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 3 (13), 83-85.

Sostav dlia lechenyia vospalytelnыkh zabolevanyi LOR orhanov : pat TJ 1063 Respublyka Tadzhykystan. № 1901381 ; zaiavl. 30.12.19 ; opubl. 17.02.20.

Musozoda, S. M., Rakhmonov, A. U., Makhsudov, K. S., Shpychak, O. S., Musoev, R. S., Kholova, Sh. S. et al. (2019). Anatomycheskoe stroenye assymyliatsyonnoho apparata shalfeia muskatnoho (Salvia scrlareae L.), proyzrastaiushcheho v Tadzhykystane. Nauka y ynnovatsyia, 4, 134-140.

Derzhavna farmakopeia Ukrainy : v 3 t. T. 1. (2015) / DP «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv». 2-e vyd. Kharkiv.

Kozhem’iakin, Yu. M., Khromov, O. S., Filonenko. M. A., Saifetdynova, H. A. (2002). Naukovo-praktychni rekomendatsii z utrymannia laboratornykh tvaryn ta roboty z nymy. Kyiv.

Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes (2010). Official Journal of the European Union, L 276, 33-79.

Doklinichni doslidzhennia likarskykh zasobiv : metod. rek. (2001). / za red. chlen-kor. AMN Ukrainy O. V. Stefanova. Kyiv.

Welu, G. G., Yimer, E. M., Hailu, H. G., Bhoumik, D., Lema, M. M. (2020). In Vivo Diuretic Activity of Hydromethanolic Extract and Solvent Fractions of the Root Bark of Clerodendrum myricoides Hochst. (Lamiaceae). Evidence-based complementary and alternative medicine, 2020. doi: 10.1155/2020/1718708.

Meharie, B. G., Tunta, T. A. (2020). Evaluation of Diuretic Activity and Phytochemical Contents of Aqueous Extract of the Shoot Apex of Podocarpus falcactus. Journal of experimental pharmacology, 12, 629-641. doi: 10.2147/JEP.S287277.

Ayele, M., Makonnen, E., Ayele, A. G., Tolcha, Y. (2020). Evaluation of the Diuretic Activity of the Aqueous and 80 % Methanol Extracts of Ficus sur Forssk (Moraceae) Leaves in Saline-loaded Rats. Journal of experimental pharmacology, 12, 619-627. doi: 10.2147/JEP.S283571.

Indrayan, A., Malhotra, K. R. (2018). Medical biostatistics. 4th ed. Boca Raton.

Dopomizhni rechovyny v tekhnolohii likiv: vplyv na tekhnolohichni, spozhyvchi, ekonomichni kharakterystyky i terapevtychnu efektyvnist : navch. posib. dlia studentiv vyshch. farmats. navch. zakl. (2010). / avt.-uklad.: I. M. Pertsev ta in. ; za red. I. M. Pertseva. Kharkiv.

Downloads

Published

2024-03-20

Issue

Section

Articles